Stocks · US
TECH
XNAS
Bio-Techne Corp.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E62.59x
P/B5.40x
P/S9.37x
EPS$1.16
ROE8.63%
ROA7.03%
Dividend yield0.44%
EV/EBITDA32.40x
Debt/Equity0.09
Free cash flow$263M
Returns and 52-week range
1W+0.07%
1M+0.00%
3M+2.07%
6M+34.55%
1Y+15.06%
YTD+21.42%
52W high$72.69
52W low$43.20
From 52W high-0.36%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| DaVita Inc. | $11.4B | 13.45 | — | -1.95% |
| Elanco Animal Health Incorporated Common Stock | $11.2B | — | 1.71 | -8.24% |
| Madrigal Pharmaceuticals, Inc. Common Stock | $11.4B | — | 21.78 | -8.25% |
| BioMarin Pharmaceuticals Inc | $11.1B | 152.64 | 1.76 | -15.50% |
| BrightSpring Health Services, Inc. Common Stock | $12.3B | 33.52 | 5.99 | +4.97% |
| 이뮤니티바이오 | $11.0B | — | — | +19.93% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.